Sign Up Today and Learn More About Novadip Biosciences Stock
Invest in or calculate the value of your shares in Novadip Biosciences or other pre-IPO companies through EquityZen's platform.
Novadip Biosciences Stock (NOBO)
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
About Novadip Biosciences Stock
Founded
2013
Industries
Software, Artificial Intelligence, Data and Analytics
Novadip Biosciences Press Mentions
Stay in the know about the latest news on Novadip Biosciences
Novadip appoints Soumya Chandramouli as Chief Financial Officer
pharmiweb • Apr 02, 2025
Results from Novadip phase 1b/2a trial reveal 88% efficacy
pharmafile • Jan 28, 2025
Novadip appoints Drew Trivisonno to the board of directors to drive financial and business development
pharmiweb • Jan 09, 2025
NOVADIP Biosciences S.A. on LinkedIn: #novadip #boneregeneration #innovativemedicines #orphandrug…
linkedin • May 24, 2024
Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs
prnewswire • Feb 18, 2024
Novadip Biosciences Management
Leadership team at Novadip Biosciences
Board Member
Franssen Christina
Board Member
Jason Zhou
Join now and verify your accreditation status to gain access to:
- Novadip Biosciences Current Valuation
- Novadip Biosciences Stock Price
- Novadip Biosciences Management
- Available deals in Novadip Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Novadip Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Novadip Biosciences Revenue and Financials
- Novadip Biosciences Highlights
- Novadip Biosciences Business Model
- Novadip Biosciences Risk Factors
- Novadip Biosciences Research Report from SACRA Research
Trading Novadip Biosciences Stock
How to invest in Novadip Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Novadip Biosciences through EquityZen funds. These investments are made available by existing Novadip Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Novadip Biosciences stock?
Shareholders can sell their Novadip Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
